CAM
OBIO icon

Cormorant Asset Management’s Orchestra BioMed OBIO Stock Holding History

Cormorant Asset Management’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-240,000
Closed -$2.45M – 100
2021
Q2 		$2.45M Sell
240,000
-560,000
-70% -$5.79M 0.1% 91
2021
Q1 		$8.98M Hold
800,000
– – 0.26% 75
2020
Q4 		$10.2M Hold
800,000
– – 0.3% 63
2020
Q3 		$8.8M Buy
+800,000
New +$8.98M 0.39% 62

Other funds holding OBIO

DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Amitell Capital Singapore $62.4M AUM 75.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return